Quantcast

Latest Tigatuzumab Stories

2014-04-03 12:30:35

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth SummaryGBI Research, has released the pharma report "Monoclonal...

2014-02-21 08:26:00

DALLAS, February 21, 2014 /PRNewswire/ -- RnRMarketResearch.com offers cancer monoclonal antibodies market (mABs) research reports covering pipeline analysis as well as monoclonal antibodies market forecasts in breast cancer, colorectal cancer as well as gastric and esophageal cancers to 2019. There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient's lifespan; Avastin, Erbitux and...

2008-11-05 09:00:34

ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) (IMUC), a biotechnology company, today announced that the company's president and chief executive officer, Manish Singh, Ph.D., will make a company presentation at the Rodman & Renshaw 10th Annual Healthcare Conference. The presentation will be webcast and will occur at 4:55 p.m. EST on Tuesday, November 11, 2008 at the New York Palace Hotel in New York City. The presentations will be audio webcast live and available for replay from...

2008-11-04 09:00:29

REDWOOD CITY, Calif., Nov. 4 /PRNewswire/ -- OncoMed Pharmaceuticals, a clinical-stage company developing novel antibody therapeutics that target cancer stem cells, today announced the successful completion of the final tranche of its Series B financing round, raising $93 million. This tranche brings the total Series B financing to $154 million. New investor Nomura Phase4 Ventures participated in the financing along with existing OncoMed investors. Proceeds from the financing will support...

2008-10-22 09:00:42

ImmunoCellular Therapeutics, a biotechnology company, has received two separate US patents relating to the company's monoclonal antibody therapeutics. The inventions cover methods for the detection of certain specific epitopes in the small cell lung cancer (SCLC) patient and for treating those patients with the company's monoclonal antibodies in a targeted manner. ImmunoCellular Therapeutics's (IMUC's) lead monoclonal antibody product candidate, ICT-109, which has demonstrated encouraging...

2008-10-21 09:00:54

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced the issuance of two separate U.S. patents relating to the company's monoclonal antibody therapeutics. Patents No. 7,435,415 and No. 7,435,554 are both entitled "Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)." The inventions cover methods for the detection of certain specific epitopes in the SCLC patient and for treating those patients...

2008-07-24 12:01:22

ImmunoCellular Therapeutics, a biotechnology company, has signed a research agreement with UK-based biotechnology company Antitope for the humanization of IMUC's monoclonal antibodies. ImmunoCellular Therapeutics (IMUC) is advancing its monoclonal antibodies toward clinical trials, and humanizing the antibodies will provide for a safer therapeutic with less immunogenicity potential. IMUC, through its recent acquisition of monoclonal antibody-related technology from Molecular Discoveries,...

2008-06-20 12:00:47

ImmunoCellular Therapeutics has signed a research agreement with George Mason University for the development of a blood test to detect small cell lung cancer and pancreatic cancer using IMUC's monoclonal antibody technology. The blood-based test would be designed to look for certain markers for the cancers potentially allowing for early detection of these cancers as well as assisting the selection of patients most likely to respond to the company's monoclonal antibody therapy, ICT-109....


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'